Premature STEMI in Men and Women: Current Clinical Features and Improvements in Management and Prognosis

Rebeca Lorca; Isaac Pascual; Andrea Aparicio; Alejandro Junco-Vicente; Rut Alvarez-Velasco; Noemi Barja; Luis Roces; Alfonso Suárez-Cuervo; Rocio Diaz; Cesar Moris; Daniel Hernandez-Vaquero; Pablo Avanzas

doi:10.3390/jcm10061314

Premature STEMI in Men and Women: Current Clinical Features and Improvements in Management and Prognosis

J Clin Med. 2021 Mar 23;10(6):1314. doi: 10.3390/jcm10061314.

Authors

Rebeca Lorca^{1

2}, Isaac Pascual^{1

2}, Andrea Aparicio¹, Alejandro Junco-Vicente¹, Rut Alvarez-Velasco¹, Noemi Barja¹, Luis Roces³, Alfonso Suárez-Cuervo¹, Rocio Diaz^{1

2}, Cesar Moris^{1

2}, Daniel Hernandez-Vaquero^{1

2}, Pablo Avanzas^{1

2}

Affiliations

¹ Heart Area, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
² Instituto de Investigación Sanitaria del Princpado de Asturias, ISPA, 33011 Oviedo, Spain.
³ Anestesiología, Reanimación y Terapéutica del Dolor, Completo Asistencial Universitario de Salamanca, 37007 Salamanca, Spain.

Abstract

Background: Coronary artery disease (CAD) is the most frequent cause of ST-segment elevation myocardial infarction (STEMI). Etiopathogenic and prognostic characteristics in young patients may differ from older patients and young women may present worse outcomes than men. We aimed to evaluate the clinical characteristics and prognosis of men and women with premature STEMI.

Methods: A total 1404 consecutive patients were referred to our institution for emergency cardiac catheterization due to STEMI suspicion (1 January 2014-31 December 2018). Patients with confirmed premature (<55 years old in men and <60 in women) STEMI (366 patients, 83% men and 17% women) were included (359 atherothrombotic and 7 spontaneous coronary artery dissection (SCAD)).

Results: Premature STEMI patients had a high prevalence of classical cardiovascular risk factors. Mean follow-up was 4.1 years (±1.75 SD). Mortality rates, re-hospitalization, and hospital stay showed no significant differences between sexes. More than 10% of women with premature STEMI suffered SCAD. There were no significant differences between sexes, neither among cholesterol levels nor in hypolipemiant therapy. The global survival rates were similar to that expected in the general population of the same sex and age in our region with a significantly higher excess of mortality at 6 years among men compared with the general population.

Conclusion: Our results showed a high incidence of cardiovascular risk factors, a high prevalence of SCAD among young women, and a generally good prognosis after standardized treatment. During follow-up, 23% suffered a major cardiovascular event (MACE), without significant differences between sexes and observed survival at 1, 3, and 6 years of follow-up was 96.57% (95% CI 94.04-98.04), 95.64% (95% CI 92.87-97.35), and 94.5% (95% CI 91.12-97.66). An extra effort to prevent/delay STEMI should be invested focusing on smoking avoidance and optimal hypolipemiant treatment both in primary and secondary prevention.

Keywords: ST-segment–elevation myocardial infarction (STEMI); coronary artery disease (CAD); premature STEMI.